South & Central America Dry Eye Products Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)

No. of Pages: 94    |    Report Code: TIPRE00016265    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Dry Eye Products Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South & Central America Dry Eye Products Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South & Central America Dry Eye Products Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Rising Prevalence of Dry Eye
  • 5.1.3 Upsurge in Geriatric Population
5.2 Market Opportunities
  • 5.2.1 Increasing Initiatives for Eye Care Awareness
5.3 Future Trends
  • 5.3.1 Expanding Product Pipeline
5.4 Impact of Drivers and Restraints

6. South & Central America Dry Eye Products Market Regional Analysis

6.1 South & Central America Dry Eye Products Market Overview
6.2 South & Central America Dry Eye Products Market Revenue 2021-2031 (US$ Million)
6.3 South & Central America Dry Eye Products Market Forecast Analysis

7. South & Central America Dry Eye Products Market Analysis – by Product

7.1 Artificial Tears
  • 7.1.1 Overview
  • 7.1.2 Artificial Tears: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Anti-Inflammatory Drugs
  • 7.2.1 Overview
  • 7.2.2 Anti-Inflammatory Drugs: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Punctal Plugs
  • 7.3.1 Overview
  • 7.3.2 Punctal Plugs: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Secretagogues
  • 7.4.1 Overview
  • 7.4.2 Secretagogues: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Oral Omega Supplements
  • 7.5.1 Overview
  • 7.5.2 Oral Omega Supplements: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Dry Eye Products Market Analysis – by Dosage Form

8.1 Eye Drops
  • 8.1.1 Overview
  • 8.1.2 Eye Drops: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Gel
  • 8.2.1 Overview
  • 8.2.2 Gel: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Capsules
  • 8.3.1 Overview
  • 8.3.2 Capsules: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Tablets
  • 8.4.1 Overview
  • 8.4.2 Tablets: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

9. South & Central America Dry Eye Products Market Analysis – by Type

9.1 OTC
  • 9.1.1 Overview
  • 9.1.2 Tablets: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Prescription
  • 9.2.1 Overview
  • 9.2.2 Tablets: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

10. South & Central America Dry Eye Products Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South & Central America Dry Eye Products Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 10.1.1.1 South & Central America Dry Eye Products Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.1.1 Brazil: South & Central America Dry Eye Products Market Breakdown, by Product
    • 10.1.1.1.2 Brazil: South & Central America Dry Eye Products Market Breakdown, by Dosage Form
    • 10.1.1.1.3 Brazil: South & Central America Dry Eye Products Market Breakdown, by Type
  • 10.1.1.2 Argentina: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.2.1 Argentina: South & Central America Dry Eye Products Market Breakdown, by Product
    • 10.1.1.2.2 Argentina: South & Central America Dry Eye Products Market Breakdown, by Dosage Form
    • 10.1.1.2.3 Argentina: South & Central America Dry Eye Products Market Breakdown, by Type
  • 10.1.1.3 Rest of South and Central America : South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South & Central America Dry Eye Products Market Breakdown, by Product
    • 10.1.1.3.2 Rest of South and Central America : South & Central America Dry Eye Products Market Breakdown, by Dosage Form
    • 10.1.1.3.3 Rest of South and Central America : South & Central America Dry Eye Products Market Breakdown, by Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South & Central America Dry Eye Products Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Santen Pharmaceutical Co Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Johnson & Johnson
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 OASIS Medical
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 URSAPHARM Arzneimittel GmbH
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Rohto Pharmaceutical Co Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 OCuSOFT Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Bausch Health Companies Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 AbbVie Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Farmigea SpA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Alcon AG
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - S Market

  1. Santen Pharmaceutical Co Ltd
  2. Johnson & Johnson
  3. OASIS Medical
  4. URSAPHARM Arzneimittel GmbH
  5. Rohto Pharmaceutical Co Ltd
  6. OCuSOFT Inc.
  7. Bausch Health Companies Inc
  8. AbbVie Inc
  9. Farmigea SpA
  10. Alcon AG